IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
IQV'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
IQVIA Holdings Inc'in en son EPS'si $2.9 olup, $2.84 beklentilerini vurmak.
IQVIA Holdings Inc IQV'ün son çeyrekteki geliri nasıl performans gösterdi?
IQVIA Holdings Inc'in son çeyrek geliri $2.9
IQVIA Holdings Inc'in gelir tahmini nedir?
20 Wall Street analistine göre, IQVIA Holdings Inc'in gelir tahmini $4.51B ile $4.12B arasında değişmektedir.
IQVIA Holdings Inc'in kazanç kalite puanı nedir?
IQVIA Holdings Inc'in kazanç kalite puanı B+/57.842556'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
IQVIA Holdings Inc kazançlarını ne zaman rapor eder?
IQVIA Holdings Inc'in bir sonraki kazanç raporu 2026-08-03'te bekleniyor